Core Points - The company has announced a share repurchase plan, allowing for the buyback of shares at a price not exceeding RMB 10.00 per share, with a total repurchase amount between RMB 100 million and RMB 200 million, to be executed within 12 months from the board's approval date [6][7] - As of September 30, 2025, the company has repurchased a total of 2.0055 million shares, with a cumulative repurchase amount of RMB 12.089 million (excluding transaction fees) [7] - The company is currently involved in legal proceedings due to a case involving the forgery of company seals, with 14 lawsuits from primary distributors totaling RMB 69.5026 million and 10 lawsuits from secondary distributors totaling RMB 17.0766 million [7] Financial Data - The financial statements for the third quarter have not been audited [3] - The company has confirmed that the financial information in the quarterly report is true, accurate, and complete, with no false records or significant omissions [2] - The company has not reported any non-recurring gains or losses for the current period [4][5]
济民健康管理股份有限公司2025年第三季度报告